This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This language would require suppliers to adhere to specified actions that are “consistent with the Framework” (although the bills do not specify what these actions will be) and provide “appropriate access to data, models, and parameters…to enable sufficient test and evaluation, verification, and validation.” Register now by clicking here.
Federal contractors must maintain written affirmative action plans, which are subject to evaluation by the Office of Federal Contract Compliance Programs (OFCCP). Certain modifications may necessitate preliminary pricenegotiations to protect the governments interests.
The first group of negotiatedprices are for 10 Medicare Part D drugs that treat a variety of conditions including cardiovascular disease, diabetes, autoimmune diseases and cancer. The negotiatedpricing is the first in a series that will be conducted through the Medicare Drug PriceNegotiation Program.
Relatedly, the Department is authorized to evaluate risks associated with the likelihood that an IaaS product or provider may be used for malicious cyber-enabled activity, and recommend remediation measures to address such risks. Access the recording here. For any assistance, please contact Michael Hanafin at mhanafin@thecgp.org.
The AISIC will develop guidelines for “red-teaming, capability evaluations, risk management, safety and security, and watermarking synthetic content,” and will be housed within the U.S. Similar to the recent OASIS+ procurement, Alliant 3 will utilize a self-scoring system to evaluate a contractor’s status as a BIC solution provider.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content